Cefradin Pharbaco may be available in the countries listed below.
Ingredient matches for Cefradin Pharbaco
Cefradine
Cefradine is reported as an ingredient of Cefradin Pharbaco in the following countries:
- Vietnam
International Drug Name Search
Sunday, September 19, 2010
Friday, September 17, 2010
Ikelan
Ikelan may be available in the countries listed below.
Ingredient matches for Ikelan
Buflomedil
Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Ikelan in the following countries:
- China
International Drug Name Search
Tuesday, September 14, 2010
Benzonatate
Benzonatate, a non-narcotic oral antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl p(butylamino) benzoate; with a molecular weight of 603.7.
Each soft gelatin capsule, for oral administration, contains 100 mg or 200 mg Benzonatate USP. In addition, each capsule contains the following inactive ingredients: D&C Yellow No. 10, gelatin, glycerin, and purified water.
Benzonatate - Clinical Pharmacology
Benzonatate acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. It begins to act within 15 to 20 minutes and its effect lasts for 3 to 8 hours. Benzonatate has no inhibitory effect on the respiratory center in recommended dosage.
Indications and Usage for Benzonatate
Benzonatate is indicated for the symptomatic relief of cough.
Contraindications
Hypersensitivity to Benzonatate or related compounds.
Warnings
Hypersensitivity
Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures.
Psychiatric Effects
Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking Benzonatate in combination with other prescribed drugs.
Accidental Ingestion and Death in Children
Keep Benzonatate out of reach of children. Accidental ingestion of Benzonatate resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE).
Precautions
Benzonatate is chemically related to anesthetic agents of the para-amino-benzoic acid class (e.g. procaine; tetracaine) and has been associated with adverse CNS effects possibly related to a prior sensitivity to related agents or interaction with concomitant medication.
Information for patients:
Swallow Benzonatate Capsules whole. Do not break, chew, dissolve, cut, or crush Benzonatate capsules. Release of Benzonatate from the capsule in the mouth can produce a temporary local anesthesia of the oral mucosa and choking could occur. If numbness or tingling of the tongue, mouth, throat, or face occurs, refrain from oral ingestion of food or liquids until the numbness has resolved. If the symptoms worsen or persist, seek medical attention.
Keep Benzonatate out of reach of children. Accidental ingestion resulting in death has been reported in children. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. Signs and symptoms may include restlessness, tremors, convulsions, coma and cardiac arrest. If accidental ingestion occurs, seek medical attention immediately.
Overdosage resulting in death may occur in adults.
Do not exceed a single dose of 200 mg and a total daily dosage of 600 mg. If you miss a dose of Benzonatate, skip that dose and take the next dose at the next scheduled time. Do not take 2 doses of Benzonatate at one time.
Usage in Pregnancy:
Pregnancy Category C.
Animal reproduction studies have not been conducted with Benzonatate. It is also not known whether Benzonatate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzonatate should be given to a pregnant woman only if clearly needed.
Nursing mothers:
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk caution should be exercised when Benzonatate is administered to a nursing woman.
Carcinogenesis, mutagenesis, impairment of fertility:
Carcinogenicity, mutagenicity, and reproduction studies have not been conducted with Benzonatate.
Pediatric Use:
Safety and effectiveness in children below the age of 10 have not been established. Accidental ingestion resulting in death has been reported in children below age 10. Keep out of reach of children.
Adverse Reactions
Potential Adverse Reactions to Benzonatate may include:
Hypersensitivity reactions including bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule.
CNS: sedation; headache; dizziness; mental confusion; visual hallucinations.
GI: constipation; nausea; GI upset.
Dermatologic: pruritus; skin eruptions.
Other: nasal congestion; sensation of burning in the eyes; vague “chilly” sensation; numbness of the chest; hypersensitivity.
Deliberate or accidental overdose has resulted in death, particularly in children.
Overdosage
Intentional and unintentional overdose may result in death, particularly in children.
The drug is chemically related to tetracaine and other topical anesthetics and shares various aspects of their pharmacology and toxicology. Drugs of this type are generally well absorbed after ingestion.
Signs and Symptoms:
The signs and symptoms of overdose of Benzonatate have been reported within 15-20 minutes. If capsules are chewed or dissolved in the mouth, oropharyngeal anesthesia will develop rapidly, which may cause choking and airway compromise.
CNS stimulation may cause restlessness and tremors which may proceed to clonic convulsions followed by profound CNS depression. Convulsions, coma, cerebral edema and cardiac arrest leading to death have been reported within 1 hour of ingestion.
Treatment:
In case of overdose, seek medical attention immediately. Evacuate gastric contents and administer copious amounts of activated charcoal slurry. Even in the conscious patient, cough and gag reflexes may be so depressed as to necessitate special attention to protection against aspiration of gastric contents and orally administered materials. Convulsions should be treated with a short-acting barbiturate given intravenously and carefully titrated for the smallest effective dosage. Intensive support of respiration and cardiovascular-renal function is an essential feature of the treatment of severe intoxication from overdosage.
Do not use CNS stimulants.
Benzonatate Dosage and Administration
Adults and Children over 10 years of age: Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. Benzonatate should be swallowed whole. Benzonatate Capsules are not to be broken, chewed, dissolved, cut or crushed.
How is Benzonatate Supplied
Benzonatate Capsules USP, 100 mg: Yellow soft gelatin capsules, imprinted with “PA46”, available in bottles of 100’s and 500’s.
Benzonatate Capsules USP, 200 mg: Yellow soft gelatin capsules, imprinted with “PA83”, available in bottles of 100’s.
The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F) [See USP].
Dispense in a tight, light-resistant container as defined in USP/NF.
Manufactured by:
BANNER PHARMACAPS INC.;
High Point, NC 27265
Distributed by:
TEVA PHARMACEUTICALS USA
Sellersville, PA 18960
Revised February 2011
PRINCIPAL DISPLAY PANEL
Benzonatate Capsules, USP 200 mg 100s Label Text
NDC 0555-1883-02
Benzonatate
Capsules, USP
200 mg
PROTECT FROM LIGHT
Rx only
100 Soft Gelatin Capsules
TEVA
| Benzonatate Benzonatate capsule | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA081297 | 11/14/2010 | |
| Labeler - Barr Laboratories Inc. (802716563) |
More Benzonatate resources
- Benzonatate Side Effects (in more detail)
- Benzonatate Dosage
- Benzonatate Use in Pregnancy & Breastfeeding
- Drug Images
- Benzonatate Drug Interactions
- Benzonatate Support Group
- 42 Reviews for Benzonatate - Add your own review/rating
- Benzonatate Professional Patient Advice (Wolters Kluwer)
- Benzonatate MedFacts Consumer Leaflet (Wolters Kluwer)
- Benzonatate Monograph (AHFS DI)
- benzonatate Advanced Consumer (Micromedex) - Includes Dosage Information
- benzonatate Concise Consumer Information (Cerner Multum)
Compare Benzonatate with other medications
- Cough
Wednesday, September 8, 2010
Mukoseptonex
Mukoseptonex may be available in the countries listed below.
Ingredient matches for Mukoseptonex
Carbaethopendecine Bromide
Carbaethopendecine Bromide is reported as an ingredient of Mukoseptonex in the following countries:
- Czech Republic
- Slovakia
International Drug Name Search
Monday, September 6, 2010
Doxil
Generic Name: doxorubicin hydrochloride liposome (Intravenous route)
dox-oh-ROO-bi-sin hye-droe-KLOR-ide LYE-poh-some
Intravenous route(Solution)
Myocardial damage may lead to congestive heart failure and may be encountered as the total cumulative dose of doxorubicin hydrochloride (HCl) approaches 550 mg/m(2). Cardiac toxicity may also occur at lower cumulative doses with mediastinal irradiation or concurrent cardiotoxic agents. Serious and sometimes life-threatening or fatal allergic/anaphylactoid-like infusion reactions have been reported. Administer at an initial rate of 1 mg/min to minimize the risk of infusion reactions. Severe myelosuppression may occur with therapy. Reduce dosage in patients with impaired hepatic function. Doxorubicin HCl liposome should not be substituted for doxorubicin HCl on a mg per mg basis .
Commonly used brand name(s)
In the U.S.
- Doxil
Available Dosage Forms:
- Solution
Therapeutic Class: Antineoplastic Agent
Chemical Class: Anthracycline
Uses For Doxil
Liposomal doxorubicin belongs to the general group of medicines known as antineoplastics. It is used to treat patients with ovarian cancer, and Kaposi's Sarcoma in patients with human immunodeficiency virus (HIV). Liposomal doxorubicin is also used together with bortezomib to treat multiple myeloma in patients who have not yet received bortezomib in the past and have received at least one prior treatment .
Liposomal doxorubicin seems to interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by liposomal doxorubicin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
Before you begin treatment with liposomal doxorubicin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Liposomal doxorubicin is to be administered only by or under the immediate supervision of your doctor.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, liposomal doxorubicin is used in certain patients with the following medical conditions:
- Cancer of the breast
- Multiple myeloma, in combination with vincristine and dexamethasone
Before Using Doxil
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
There is no specific information comparing the use of liposomal doxorubicin in children with use in any other age group. Safety and efficacy of liposomal doxorubicin in children have not been established. However, problems are more likely to occur in children younger than 2 years of age, who are usually more sensitive to the effects of the active ingredient, doxorubicin.
Geriatric
This medicine has been tested in a limited number of patients 60 years of age or older and has not been shown to cause different side effects in older people than it does in younger adults. However, problems are more likely to occur in the elderly, who are usually more sensitive to the effects of the active ingredient, doxorubicin. The elderly are also more likely to have blood problems.
Interactions with Medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
- Rotavirus Vaccine, Live
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Adenovirus Vaccine Type 4, Live
- Adenovirus Vaccine Type 7, Live
- Bacillus of Calmette and Guerin Vaccine, Live
- Cisplatin
- Influenza Virus Vaccine, Live
- Measles Virus Vaccine, Live
- Mumps Virus Vaccine, Live
- Rotavirus Vaccine, Live
- Rubella Virus Vaccine, Live
- Smallpox Vaccine
- Trastuzumab
- Typhoid Vaccine
- Varicella Virus Vaccine
- Yellow Fever Vaccine
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Paclitaxel
Interactions with Food/Tobacco/Alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
- Chickenpox (including recent exposure) or
- Herpes zoster (shingles)—Risk of severe disease affecting other parts of the body.
- Heart disease—Risk of heart problems caused by liposomal doxorubicin may be increased.
- Infection—Liposomal doxorubicin can decrease your body's ability to fight infection.
- Liver disease—Effects of liposomal doxorubicin may be increased because of slower removal from the body.
Proper Use of Doxil
Liposomal doxorubicin is sometimes given together with certain other medicines. If you are using a combination of medicines, it is important that you receive each one at the proper time. If you are taking some of these medicines by mouth, ask your health care professional to help you plan a way to take them at the right times.
While you are receiving liposomal doxorubicin, your doctor may want you to drink extra fluids so that you will pass more urine. This will help prevent kidney problems and keep your kidneys working well.
This medicine often causes nausea and vomiting. However, it is very important that you continue to receive it, even if you begin to feel ill. Ask your health care professional for ways to lessen these effects.
Dosing
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
Precautions While Using Doxil
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Your doctor will need to check your blood for unwanted effects .
Check with your doctor immediately if you are having chest pain or discomfort, fast or irregular heartbeat, shortness of breath, swelling of the feet and lower legs, or troubled breathing. These could be symptoms of a serious heart problem .
Acute infusion-related reactions can occur during treatment with this medicine. Symptoms of this reaction include: flushing; shortness of breath; swelling of the face; headache; chills; chest pain; back pain; tightness in chest and throat; fever; itching skin; rash; bluish color of fingernails, lips, skin, palms, or nail beds; difficulty breathing; wheezing; fainting; lightheadedness; or fast, pounding, or irregular heartbeat or pulse .
This medicine may cause hand-foot syndrome. Check with your doctor right away if you experience tingling or burning, redness, swelling, blistering, or small sores on the palms of your hands or soles of your feet.
You should not receive this medicine if you are pregnant or breastfeeding. Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using the medicine, tell your doctor right away .
While you are being treated with liposomal doxorubicin, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Liposomal doxorubicin may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral poliovirus vaccine since there is a chance they could pass the poliovirus on to you. Also, avoid persons who have taken oral poliovirus vaccine. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and the mouth.
Liposomal doxorubicin can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in urine or stools; or pinpoint red spots on your skin.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid contact sports or other situations where bruising or injury can occur.
If liposomal doxorubicin accidentally seeps out of the vein into which it is injected, it may damage some tissues and cause scarring. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the place of injection.
Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
Doxil Side Effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
More common–in any treatment group
- Black, tarry stools
- blistering, peeling, redness, and/or swelling of palms of hands or bottoms of feet
- blood in urine or stools
- chills
- cough or hoarseness
- facial swelling
- fever
- headache
- loss of strength and energy
- low blood pressure
- lower back or side pain
- numbness, pain, tingling, or unusual sensations in palms of hands or bottoms of feet
- painful or difficult urination
- pinpoint red spots on skin
- shortness of breath
- sore throat
- sores in mouth and on lips
- unusual bleeding or bruising
- unusual tiredness or weakness
- Skin rash or itching
- Chest pain
- decreased urine output
- dilated neck veins
- extreme fatigue
- irregular breathing
- irregular heartbeat
- shortness of breath
- swelling of face, fingers, feet, or lower legs
- tightness in chest
- troubled breathing
- weight gain
- wheezing
- yellowing of the eyes and skin
- Cough
- fever
- pain at place of injection
- troubled breathing
- wheezing
- Blurred or loss of vision
- eye pain
- flushed, dry skin
- frequent urination
- fruit-like breath odor
- unusual thirst
- Bloating or swelling of face, hands, lower legs, and/or feet
- chest pain
- cough or hoarseness
- decreased urination
- fever or chills
- lower back or side pain
- painful or difficult urination
- rapid weight gain
- Cough
- difficulty swallowing
- hives
- pain at place of injection
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- shortness of breath
- tightness in chest
- wheezing
- Black, tarry stools
- blood in urine or stools
- cough or hoarseness accompanied by fever or chills
- fever or chills
- lower back or side pain accompanied by fever or chills
- painful or difficult urination accompanied by fever or chills
- pinpoint red spots on skin
- sores in mouth and on lips
- unusual bleeding or bruising
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common–in any treatment group
- Diarrhea
- nausea
- vomiting
- Back pain
- difficulty swallowing
- dizziness
- Creamy white, curd-like patches in mouth or throat
- pain when eating or swallowing
- Constipation
- headache
- Abdominal or stomach pain
- changes in the lining of the mouth or nose
- constipation
- headache
- loss of appetite
- pain
- rash
- sore throat
- tingling, burning, or prickly sensations
- Anxiety
- bad, unusual, or unpleasant (after)taste
- burning, dry, or itching eyes
- change in taste
- difficulty swallowing
- excessive tearing
- itching skin
- muscle aches
- redness, pain, swelling of eye, eyelid, or inner lining of eyelid
- trouble sleeping
- Change in sense of smell
- chills
- clumsiness, unsteadiness, trembling, or other problems with muscle control or coordination
- cough
- fever
- general feeling of discomfort or illness
- increased white vaginal discharge
- joint pain
- nausea
- shakiness and unsteady walk
- shivering
- sore throat
- sweating
- thinking abnormal
- vomiting
Liposomal doxorubicin causes the urine to turn reddish in color, which may stain clothes. This is not blood. It is to be expected and only lasts for 1 or 2 days after each dose is given.
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common—for patients being treated for ovarian cancer
- Dry skin
- Change in skin color
This medicine often causes a temporary and total loss of hair. After treatment with liposomal doxorubicin has ended, normal hair growth should return.
After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:
- Fast or irregular heartbeat
- shortness of breath
- swelling of feet and lower legs
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Doxil side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
More Doxil resources
- Doxil Side Effects (in more detail)
- Doxil Use in Pregnancy & Breastfeeding
- Doxil Drug Interactions
- Doxil Support Group
- 0 Reviews for Doxil - Add your own review/rating
- Doxil Prescribing Information (FDA)
- Doxil Concise Consumer Information (Cerner Multum)
- Doxil MedFacts Consumer Leaflet (Wolters Kluwer)
Compare Doxil with other medications
- Kaposi's Sarcoma
- Multiple Myeloma
- Ovarian Cancer
Gliclazide Winthrop
Gliclazide Winthrop may be available in the countries listed below.
Ingredient matches for Gliclazide Winthrop
Gliclazide
Gliclazide is reported as an ingredient of Gliclazide Winthrop in the following countries:
- France
International Drug Name Search
Sunday, September 5, 2010
Furofutran E
Furofutran E may be available in the countries listed below.
Ingredient matches for Furofutran E
Tegafur
Tegafur is reported as an ingredient of Furofutran E in the following countries:
- Japan
International Drug Name Search
Subscribe to:
Posts (Atom)